Neridronate Sodium
奈立膦酸钠
Report date: 2025/12/24 13:38:33
NME
Base Information
Drug NameNeridronate Sodium
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2002/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAbiogen Pharma Spa
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksDrugBank